STERIS plc (NYSE:STE) Shares Acquired by Quantinno Capital Management LP

Quantinno Capital Management LP lifted its stake in shares of STERIS plc (NYSE:STE - Free Report) by 46.1% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 22,423 shares of the medical equipment provider's stock after acquiring an additional 7,071 shares during the period. Quantinno Capital Management LP's holdings in STERIS were worth $5,439,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Cetera Investment Advisers grew its stake in STERIS by 215.1% in the 1st quarter. Cetera Investment Advisers now owns 12,330 shares of the medical equipment provider's stock worth $2,772,000 after acquiring an additional 8,417 shares during the period. Cetera Advisors LLC grew its position in shares of STERIS by 53.7% in the first quarter. Cetera Advisors LLC now owns 4,164 shares of the medical equipment provider's stock valued at $936,000 after purchasing an additional 1,455 shares during the period. CWM LLC grew its position in shares of STERIS by 3.9% in the second quarter. CWM LLC now owns 2,291 shares of the medical equipment provider's stock valued at $503,000 after purchasing an additional 85 shares during the period. Simplicity Wealth LLC lifted its position in STERIS by 7.1% during the second quarter. Simplicity Wealth LLC now owns 1,546 shares of the medical equipment provider's stock worth $339,000 after buying an additional 103 shares during the period. Finally, Czech National Bank lifted its position in STERIS by 8.3% during the second quarter. Czech National Bank now owns 18,829 shares of the medical equipment provider's stock worth $4,134,000 after buying an additional 1,443 shares during the period. Hedge funds and other institutional investors own 94.69% of the company's stock.

STERIS Stock Down 0.7 %

Shares of NYSE:STE traded down $1.54 during midday trading on Friday, hitting $215.89. 604,774 shares of the company's stock traded hands, compared to its average volume of 631,314. The firm's fifty day moving average price is $222.94 and its two-hundred day moving average price is $227.75. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.55 and a current ratio of 2.41. STERIS plc has a twelve month low of $197.82 and a twelve month high of $248.24. The company has a market cap of $21.31 billion, a PE ratio of 49.29 and a beta of 0.83.

STERIS (NYSE:STE - Get Free Report) last issued its quarterly earnings data on Wednesday, November 6th. The medical equipment provider reported $2.14 EPS for the quarter, topping analysts' consensus estimates of $2.12 by $0.02. The company had revenue of $1.33 billion for the quarter, compared to analysts' expectations of $1.33 billion. STERIS had a return on equity of 13.78% and a net margin of 8.02%. The firm's quarterly revenue was up 7.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.03 earnings per share. On average, equities research analysts anticipate that STERIS plc will post 9.1 EPS for the current fiscal year.

STERIS Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 19th. Stockholders of record on Tuesday, November 19th will be paid a dividend of $0.57 per share. The ex-dividend date is Tuesday, November 19th. This represents a $2.28 dividend on an annualized basis and a dividend yield of 1.06%. STERIS's dividend payout ratio is currently 52.05%.

Insider Transactions at STERIS

In other news, SVP Cary L. Majors sold 1,682 shares of the company's stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $217.32, for a total value of $365,532.24. Following the sale, the senior vice president now owns 11,372 shares in the company, valued at approximately $2,471,363.04. This represents a 12.88 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Michael J. Tokich sold 23,332 shares of the stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $247.00, for a total transaction of $5,763,004.00. Following the transaction, the chief financial officer now directly owns 42,930 shares in the company, valued at $10,603,710. The trade was a 35.21 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.14% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on STE shares. Piper Sandler raised shares of STERIS from a "neutral" rating to an "overweight" rating and upped their price objective for the company from $230.00 to $260.00 in a research note on Thursday, October 24th. Needham & Company LLC reaffirmed a "hold" rating on shares of STERIS in a research note on Friday, November 8th. JMP Securities reissued a "market outperform" rating and set a $265.00 price objective on shares of STERIS in a research note on Monday, November 18th. Stephens reissued an "overweight" rating and set a $260.00 price objective on shares of STERIS in a research note on Thursday, November 7th. Finally, KeyCorp lifted their target price on STERIS from $255.00 to $265.00 and gave the company an "overweight" rating in a report on Tuesday, September 3rd. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $262.50.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.